81_FR_35890 81 FR 35783 - National Vaccine Injury Compensation Program; List of Petitions Received

81 FR 35783 - National Vaccine Injury Compensation Program; List of Petitions Received

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 81, Issue 107 (June 3, 2016)

Page Range35783-35785
FR Document2016-13073

The Health Resources and Services Administration (HRSA) is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by Section 2112(b)(2) of the Public Health Service (PHS) Act, as amended. While the Secretary of Health and Human Services (HHS) is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.

Federal Register, Volume 81 Issue 107 (Friday, June 3, 2016) 
[Federal Register Volume 81, Number 107 (Friday, June 3, 2016)]
[Notices]
[Pages 35783-35785]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-13073]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


National Vaccine Injury Compensation Program; List of Petitions 
Received

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
publishing this notice of petitions received under the National Vaccine 
Injury Compensation Program (the Program), as required by Section 
2112(b)(2) of the Public Health Service (PHS) Act, as amended. While 
the Secretary of Health and Human Services (HHS) is named as the 
respondent in all proceedings brought by the filing of petitions for 
compensation under the Program, the United States Court of Federal 
Claims is charged by statute with responsibility for considering and 
acting upon the petitions.

SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault 
compensation for certain individuals who have been injured by specified 
childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C. 
300aa-10 et seq. provides that those seeking compensation are to file a 
petition with the U.S. Court of Federal Claims and to serve a copy of 
the petition on the Secretary of HHS, who is named as the respondent in 
each proceeding. The Secretary has delegated this responsibility under 
the Program to

[[Page 35784]]

HRSA. The Court is directed by statute to appoint special masters who 
take evidence, conduct hearings as appropriate, and make initial 
decisions as to eligibility for, and amount of, compensation.
    A petition may be filed with respect to injuries, disabilities, 
illnesses, conditions, and deaths resulting from vaccines described in 
the Vaccine Injury Table (the Table) set forth at 42 CFR 100.3. This 
Table lists for each covered childhood vaccine the conditions that may 
lead to compensation and, for each condition, the time period for 
occurrence of the first symptom or manifestation of onset or of 
significant aggravation after vaccine administration. Compensation may 
also be awarded for conditions not listed in the Table and for 
conditions that are manifested outside the time periods specified in 
the Table, but only if the petitioner shows that the condition was 
caused by one of the listed vaccines.
    Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2), 
requires that ``[w]ithin 30 days after the Secretary receives service 
of any petition filed under section 2111 the Secretary shall publish 
notice of such petition in the Federal Register.'' Set forth below is a 
list of petitions received by HRSA on April 1, 2016, through April 30, 
2016. This list provides the name of petitioner, city and state of 
vaccination (if unknown then city and state of person or attorney 
filing claim), and case number. In cases where the Court has redacted 
the name of a petitioner and/or the case number, the list reflects such 
redaction.
    Section 2112(b)(2) also provides that the special master ``shall 
afford all interested persons an opportunity to submit relevant, 
written information'' relating to the following:
    1. The existence of evidence ``that there is not a preponderance of 
the evidence that the illness, disability, injury, condition, or death 
described in the petition is due to factors unrelated to the 
administration of the vaccine described in the petition,'' and
    2. Any allegation in a petition that the petitioner either:
    a. ``[S]ustained, or had significantly aggravated, any illness, 
disability, injury, or condition not set forth in the Vaccine Injury 
Table but which was caused by'' one of the vaccines referred to in the 
Table, or
    b. ``[S]ustained, or had significantly aggravated, any illness, 
disability, injury, or condition set forth in the Vaccine Injury Table 
the first symptom or manifestation of the onset or significant 
aggravation of which did not occur within the time period set forth in 
the Table but which was caused by a vaccine'' referred to in the Table.
    In accordance with Section 2112(b)(2), all interested persons may 
submit written information relevant to the issues described above in 
the case of the petitions listed below. Any person choosing to do so 
should file an original and three (3) copies of the information with 
the Clerk of the U.S. Court of Federal Claims at the address listed 
above (under the heading For Further Information Contact), with a copy 
to HRSA addressed to Director, Division of Injury Compensation 
Programs, Healthcare Systems Bureau, 5600 Fishers Lane, 08N146B, 
Rockville, MD 20857. The Court's caption (Petitioner's Name v. 
Secretary of Health and Human Services) and the docket number assigned 
to the petition should be used as the caption for the written 
submission. Chapter 35 of title 44, United States Code, related to 
paperwork reduction, does not apply to information required for 
purposes of carrying out the Program.

FOR FURTHER INFORMATION CONTACT: For information about requirements for 
filing petitions, and the Program in general, contact the Clerk, United 
States Court of Federal Claims, 717 Madison Place NW., Washington, DC 
20005, (202) 357-6400. For information on HRSA's role in the Program, 
contact the Director, National Vaccine Injury Compensation Program, 
5600 Fishers Lane, Room 08N146B, Rockville, MD 20857; (301) 443-6593, 
or visit our Web site at: http://www.hrsa.gov/vaccinecompensation/index.html.

    Dated: May 26, 2016.
James Macrae,
Acting Administrator.

List of Petitions Filed

1. Christopher Stephen Fennell; Sun City West, Arizona; Court of 
Federal Claims No: 16-0413V
2. Willie Johnson; Dublin, Georgia; Court of Federal Claims No: 16-
0415V
3. Maria Villanueva; Utuado, Puerto Rico; Court of Federal Claims No: 
16-0416V
4. Laura Friedel; Woodstock, Illinois; Court of Federal Claims No: 16-
0417V
5. Kathleen Mosier; Akron, Ohio; Court of Federal Claims No: 16-0418V
6. Christina Osenbach and Bryan Osenbach on behalf of B. O.; Boston, 
Massachusetts; Court of Federal Claims No: 16-0419V
7. Meredith Pyers; Columbus, Ohio; Court of Federal Claims No: 16-0421V
8. Alexandria Skeens; Granville, Ohio; Court of Federal Claims No: 16-
0423V
9. Marsha Crawford; Paris, Kentucky; Court of Federal Claims No: 16-
0428V
10. Edward McMahon; Tucson, Arizona; Court of Federal Claims No: 16-
0429V
11. Kristina Raab on behalf of J. R.; San Diego, California; Court of 
Federal Claims No: 16-0431V
12. Pella Parker; Los Angeles, California; Court of Federal Claims No: 
16-0433V
13. Michele Jacob and Craig Jacob on behalf of Ryan Jacob; New York, 
New York; Court of Federal Claims No: 16-0434V
14. Jason Guido on behalf of D. G.; Rochester, Pennsylvania; Court of 
Federal Claims No: 16-0435V
15. Carl L. Anderson; Baltimore, Maryland; Court of Federal Claims No: 
16-0436V
16. Kelsi Amen; Grand Island, Nebraska; Court of Federal Claims No: 16-
0437V
17. Martin Rausch; Avery, North Carolina; Court of Federal Claims No: 
16-0438V
18. Timothy Koller; Neenah, Wisconsin; Court of Federal Claims No: 16-
0439V
19. Christian Geideman and Erinn Geideman on behalf of H. G. G.; Menlo 
Park, California; Court of Federal Claims No: 16-0443V
20. Vilma Espada Cubano; San Juan, Puerto Rico; Court of Federal Claims 
No: 16-0444V
21. Regina Murrell; Jackson, Mississippi; Court of Federal Claims No: 
16-0445V
22. Kristen Bell; Alpharetta, Georgia; Court of Federal Claims No: 16-
0450V
23. Lorraine Sofia; Lyndhurst, New Jersey; Court of Federal Claims No: 
16-0452V
24. Arlene Sandman; Boston, Massachusetts; Court of Federal Claims No: 
16-0453V
25. Frederick Green; Newport, Rhode Island; Court of Federal Claims No: 
16-0454V
26. Linda Commesso; Boston, Massachusetts; Court of Federal Claims No: 
16-0455V
27. Isaac Watson; Indianapolis, Indiana; Court of Federal Claims No: 
16-0456V
28. Patricia Swanson; Beverly, Massachusetts; Court of Federal Claims 
No: 16-0457V
29. Betty D. Backman; Manhattan, Kansas; Court of Federal Claims No: 
16-0458V
30. Sandra E. Williams on behalf of Richard Williams, Deceased;

[[Page 35785]]

Surprise, Arizona; Court of Federal Claims No: 16-0459V
31. Linda K. Russell; Tampa, Florida; Court of Federal Claims No: 16-
0460V
32. Steven Patton; Vienna, Virginia; Court of Federal Claims No: 16-
0461V
33. Scott Cipa; Vienna, Virginia; Court of Federal Claims No: 16-0462V
34. Jessica Buckingham; New Castle, Delaware; Court of Federal Claims 
No: 16-0463V
35. Mette Rose and Soren Rose Kjaer on behalf of F. R. K.; New York, 
New York; Court of Federal Claims No: 16-0465V
36. Mette Rose and Soren Rose Kjaer on behalf of M. R. K.; New York, 
New York; Court of Federal Claims No: 16-0466V
37. Victoria Pusateri; Southgate, Michigan; Court of Federal Claims No: 
16-0467V
38. Nathaniel Paul; Fairfax, Virginia; Court of Federal Claims No: 16-
0468V
39. Rebecca S. Melgares; Milwaukee, Wisconsin; Court of Federal Claims 
No: 16-0470V
40. Arthur L. Trollinger; Graham, North Carolina; Court of Federal 
Claims No: 16-0473V
41. Tracy E. Carrozza; Princeton, New Jersey; Court of Federal Claims 
No: 16-0474V
42. Allen O. Cabansag; Spring Valley, California; Court of Federal 
Claims No: 16-0475V
43. Luciana Desa; Washington, District of Columbia; Court of Federal 
Claims No: 16-0476V
44. Deborah Tebault on behalf of J. T.; Phoenix, Arizona; Court of 
Federal Claims No: 16-0478V
45. Stephen Vasas; Ann Arbor, Michigan; Court of Federal Claims No: 16-
0479V
46. Theresa Hibbs; Shepherdsville, Kentucky; Court of Federal Claims 
No: 16-0481V
47. Stephanie Gilbert on behalf of P. L.; Vienna, Virginia; Court of 
Federal Claims No: 16-0484V
48. Sonya Tabor; Beverly Hills, California; Court of Federal Claims No: 
16-0485V
49. The Estate of Frank Lee Kapp, Jr., Deceased; Salisbury, North 
Carolina; Court of Federal Claims No: 16-0487V
50. Leslie Lewis; Lexington, South Carolina; Court of Federal Claims 
No: 16-0488V
51. Christine Benshoff; Orwigsburg, Pennsylvania; Court of Federal 
Claims No: 16-0489V
52. Robert Hearn; Jackson, Mississippi; Court of Federal Claims No: 16-
0493V
53. John Neukom; Normangee, Texas; Court of Federal Claims No: 16-0495V
54. Heather Wright on behalf of B. W.; Washington, District of 
Columbia; Court of Federal Claims No: 16-0498V
55. Julian Henley; Scottsbluff, Nebraska; Court of Federal Claims No: 
16-0499V
56. Misty Pasco on behalf of M. P.; Phoenix, Arizona; Court of Federal 
Claims No: 16-0500V
57. Janis Pool; Lawrence, Kansas; Court of Federal Claims No: 16-0503V
58. Jeffrey A. Bales; Greensboro, North Carolina; Court of Federal 
Claims No: 16-0505V
59. Terry Bartee; Antioch, California; Court of Federal Claims No: 16-
0506V
60. Linda Barton; Lancaster, Pennsylvania; Court of Federal Claims No: 
16-0508V
61. Richard George Laux; Farmington Hills, Michigan; Court of Federal 
Claims No: 16-0509V
62. Judith A. Pannick; Flint, Michigan; Court of Federal Claims No: 16-
0510V
63. Laura Kerrin; Philadelphia, Pennsylvania; Court of Federal Claims 
No: 16-0511V
64. Rev. Andrew Thomas Moody on behalf of E. G. M.; Houston, Texas; 
Court of Federal Claims No: 16-0513V
65. James Ritchie; Ponte Vedra Beach, Florida; Court of Federal Claims 
No: 16-0514V
66. Thomas Smith; Weston, West Virginia; Court of Federal Claims No: 
16-0520V
67. Shahid Mahroof; Stony Brook, New York; Court of Federal Claims No: 
16-0521V
68. Stephanie Smith; Allentown, Pennsylvania; Court of Federal Claims 
No: 16-0522V
69. Monika Piatek on behalf of N. P.; Chicago, Illinois; Court of 
Federal Claims No: 16-0524V
70. Patricia Rubio; Bedford, New Hampshire; Court of Federal Claims No: 
16-0525V
71. Frederick Morrison; Gulf Breeze, Florida; Court of Federal Claims 
No: 16-0526V
72. Gary Schilling; Boston, Massachusetts; Court of Federal Claims No: 
16-0527V
73. Tiffany Harris on behalf of A. H.; Boston, Massachusetts; Court of 
Federal Claims No: 16-0528V
74. Lianna Roberts; Boston, Massachusetts; Court of Federal Claims No: 
16-0529V
75. Jennifer Young; Canton, Michigan; Court of Federal Claims No: 16-
0530V
76. Scott Pudalov; Boulder, Colorado; Court of Federal Claims No: 16-
0532V
77. Tracy Butler; Denver, Colorado; Court of Federal Claims No: 16-
0534V

[FR Doc. 2016-13073 Filed 6-2-16; 8:45 am]
 BILLING CODE 4165-15-P

Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices 35783 MD 20993–0002, 301–796–9001, FAX: 503A bulk drug substances list. FDA FDA welcomes the attendance of the 301–847–8533, email: PCAC@ intends to discuss the following public at its advisory committee fda.hhs.gov, or FDA Advisory nominated bulk drug substances: meetings and will make every effort to Committee Information Line, 1–800– Chrysin, cesium chloride, sodium accommodate persons with disabilities. 741–8138 (301–443–0572 in the dichloroacetate, pyruvic acid, tea tree If you require accommodations due to a Washington, DC area). A notice in the oil, and 2,3-Dimercapto-1- disability, please contact Cindy Hong at Federal Register about last minute propanesulfonic acid (DMPS). The least 7 days in advance of the meeting. modifications that impact a previously nominators of these substances will be FDA is committed to the orderly announced advisory committee meeting invited to make a short presentation conduct of its advisory committee cannot always be published quickly supporting the nomination. During the meetings. Please visit our Web site at enough to provide timely notice. afternoon session, the committee will http://www.fda.gov/ Therefore, you should always check the receive updates on certain issues to AdvisoryCommittees/ Agency’s Web site at http:// follow up on discussions from previous AboutAdvisoryCommittees/ www.fda.gov/AdvisoryCommittees/ meetings, including the option for ucm111462.htm for procedures on default.htm and scroll down to the obtaining access to investigational new public conduct during advisory appropriate advisory committee meeting drugs under expanded access. committee meetings. link, or call the advisory committee FDA intends to make background Notice of this meeting is given under information line to learn about possible material available to the public no later the Federal Advisory Committee Act (5 modifications before coming to the than 2 business days before the meeting. U.S.C. app. 2). meeting. If FDA is unable to post the background Dated: May 31, 2016. Background: Section 503A of the material on its Web site prior to the Leslie Kux, FD&C Act (21 U.S.C. 353a) describes the meeting, the background material will Associate Commissioner for Policy. conditions that must be satisfied for be made publicly available at the human drug products compounded by a [FR Doc. 2016–13169 Filed 6–2–16; 8:45 am] location of the advisory committee BILLING CODE 4164–01–P licensed pharmacist or licensed meeting, and the background material physician to be exempt from the will be posted on FDA’s Web site after following three sections of the FD&C the meeting. Background material is Act: (1) Section 501(a)(2)(B) (21 U.S.C. DEPARTMENT OF HEALTH AND available at http://www.fda.gov/ HUMAN SERVICES 351(a)(2)(B)) (concerning current good AdvisoryCommittees/Calendar/ manufacturing practice (CGMP)); (2) default.htm. Scroll down to the Health Resources and Services section 502(f)(1) (21 U.S.C. 352(f)(1)) appropriate advisory committee meeting Administration (concerning the labeling of drugs with link. adequate directions for use); and (3) National Vaccine Injury Compensation Procedure: Interested persons may section 505 (21 U.S.C. 355) (concerning Program; List of Petitions Received present data, information, or views, the approval of human drug products under new drug applications (NDAs) or orally or in writing, on issues pending AGENCY: Health Resources and Services abbreviated new drug applications before the committee. Written Administration, HHS. (ANDAs)). submissions may be made to the contact ACTION: Notice. One of the conditions that must be person on or before June 15, 2016. Oral satisfied to qualify for the exemptions presentations from the public will be SUMMARY: The Health Resources and under section 503A of the FD&C Act is scheduled between approximately 9:30 Services Administration (HRSA) is that a bulk drug substance (active a.m. and 9:40 a.m., 10:35 a.m. and 10:45 publishing this notice of petitions pharmaceutical ingredient) used in a a.m., 11:40 a.m. and 11:50 a.m., 2:15 received under the National Vaccine compounded drug product must meet p.m. and 2:25 p.m., 3:20 p.m. and 3:30 Injury Compensation Program (the one of the following criteria: (1) p.m., and 4:40 p.m. and 4:50 p.m. Those Program), as required by Section Complies with the standards of an individuals interested in making formal 2112(b)(2) of the Public Health Service applicable United States Pharmacopoeia oral presentations should notify Cindy (PHS) Act, as amended. While the (USP) or National Formulary Hong and submit a brief statement of the Secretary of Health and Human Services monograph, if a monograph exists, and general nature of the evidence or (HHS) is named as the respondent in all the USP chapter on pharmacy arguments they wish to present, the proceedings brought by the filing of compounding; (2) if an applicable names and addresses of proposed petitions for compensation under the monograph does not exist, is a participants, and an indication of the Program, the United States Court of component of a drug approved by the approximate time requested to make Federal Claims is charged by statute Secretary of Health and Human Services their presentation on or before June 10, with responsibility for considering and (the Secretary); or (3) if such a 2016. Time allotted for each acting upon the petitions. monograph does not exist and the drug presentation may be limited. If the SUPPLEMENTARY INFORMATION: The substance is not a component of a drug number of registrants requesting to Program provides a system of no-fault approved by the Secretary, appears on a speak is greater than can be reasonably compensation for certain individuals list (the ‘‘section 503A bulk drug accommodated during the scheduled who have been injured by specified substances list’’) developed by the open public hearing session, FDA may childhood vaccines. Subtitle 2 of Title Secretary through regulations issued by conduct a lottery to determine the XXI of the PHS Act, 42 U.S.C. 300aa– speakers for the scheduled open public 10 et seq. provides that those seeking mstockstill on DSK3G9T082PROD with NOTICES the Secretary (see section 503A(b)(1)(A)(i) of the FD&C Act). hearing session. The contact person will compensation are to file a petition with FDA will discuss with the committee notify interested persons regarding their the U.S. Court of Federal Claims and to drugs proposed for inclusion on the request to speak by June 13, 2016. serve a copy of the petition on the section 503A bulk drug substances list. Persons attending FDA’s advisory Secretary of HHS, who is named as the Agenda: The committee intends to committee meetings are advised that the respondent in each proceeding. The discuss six bulk drug substances Agency is not responsible for providing Secretary has delegated this nominated for inclusion on the section access to electrical outlets. responsibility under the Program to VerDate Sep<11>2014 21:20 Jun 02, 2016 Jkt 238001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\03JNN1.SGM 03JNN1

35784 Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices HRSA. The Court is directed by statute the Table but which was caused by a 8. Alexandria Skeens; Granville, Ohio; to appoint special masters who take vaccine’’ referred to in the Table. Court of Federal Claims No: 16– evidence, conduct hearings as In accordance with Section 0423V appropriate, and make initial decisions 2112(b)(2), all interested persons may 9. Marsha Crawford; Paris, Kentucky; as to eligibility for, and amount of, submit written information relevant to Court of Federal Claims No: 16– compensation. the issues described above in the case of 0428V A petition may be filed with respect the petitions listed below. Any person 10. Edward McMahon; Tucson, Arizona; to injuries, disabilities, illnesses, choosing to do so should file an original Court of Federal Claims No: 16– conditions, and deaths resulting from and three (3) copies of the information 0429V vaccines described in the Vaccine Injury with the Clerk of the U.S. Court of 11. Kristina Raab on behalf of J. R.; San Table (the Table) set forth at 42 CFR Federal Claims at the address listed Diego, California; Court of Federal 100.3. This Table lists for each covered above (under the heading FOR FURTHER Claims No: 16–0431V childhood vaccine the conditions that INFORMATION CONTACT), with a copy to 12. Pella Parker; Los Angeles, California; may lead to compensation and, for each HRSA addressed to Director, Division of Court of Federal Claims No: 16– condition, the time period for Injury Compensation Programs, 0433V occurrence of the first symptom or 13. Michele Jacob and Craig Jacob on Healthcare Systems Bureau, 5600 manifestation of onset or of significant behalf of Ryan Jacob; New York, Fishers Lane, 08N146B, Rockville, MD aggravation after vaccine New York; Court of Federal Claims 20857. The Court’s caption (Petitioner’s administration. Compensation may also No: 16–0434V Name v. Secretary of Health and Human 14. Jason Guido on behalf of D. G.; be awarded for conditions not listed in Services) and the docket number the Table and for conditions that are Rochester, Pennsylvania; Court of assigned to the petition should be used Federal Claims No: 16–0435V manifested outside the time periods as the caption for the written specified in the Table, but only if the 15. Carl L. Anderson; Baltimore, submission. Chapter 35 of title 44, Maryland; Court of Federal Claims petitioner shows that the condition was United States Code, related to caused by one of the listed vaccines. No: 16–0436V paperwork reduction, does not apply to 16. Kelsi Amen; Grand Island, Nebraska; Section 2112(b)(2) of the PHS Act, 42 information required for purposes of Court of Federal Claims No: 16– U.S.C. 300aa–12(b)(2), requires that carrying out the Program. 0437V ‘‘[w]ithin 30 days after the Secretary receives service of any petition filed FOR FURTHER INFORMATION CONTACT: For 17. Martin Rausch; Avery, North under section 2111 the Secretary shall information about requirements for Carolina; Court of Federal Claims publish notice of such petition in the filing petitions, and the Program in No: 16–0438V Federal Register.’’ Set forth below is a general, contact the Clerk, United States 18. Timothy Koller; Neenah, Wisconsin; list of petitions received by HRSA on Court of Federal Claims, 717 Madison Court of Federal Claims No: 16– April 1, 2016, through April 30, 2016. Place NW., Washington, DC 20005, 0439V (202) 357–6400. For information on 19. Christian Geideman and Erinn This list provides the name of HRSA’s role in the Program, contact the Geideman on behalf of H. G. G.; petitioner, city and state of vaccination Director, National Vaccine Injury Menlo Park, California; Court of (if unknown then city and state of Compensation Program, 5600 Fishers Federal Claims No: 16–0443V person or attorney filing claim), and 20. Vilma Espada Cubano; San Juan, case number. In cases where the Court Lane, Room 08N146B, Rockville, MD 20857; (301) 443–6593, or visit our Web Puerto Rico; Court of Federal has redacted the name of a petitioner Claims No: 16–0444V and/or the case number, the list reflects site at: http://www.hrsa.gov/vaccine compensation/index.html. 21. Regina Murrell; Jackson, such redaction. Mississippi; Court of Federal Section 2112(b)(2) also provides that Dated: May 26, 2016. Claims No: 16–0445V the special master ‘‘shall afford all James Macrae, 22. Kristen Bell; Alpharetta, Georgia; interested persons an opportunity to Acting Administrator. Court of Federal Claims No: 16– submit relevant, written information’’ 0450V relating to the following: List of Petitions Filed 23. Lorraine Sofia; Lyndhurst, New 1. The existence of evidence ‘‘that 1. Christopher Stephen Fennell; Sun Jersey; Court of Federal Claims No: there is not a preponderance of the City West, Arizona; Court of Federal 16–0452V evidence that the illness, disability, Claims No: 16–0413V 24. Arlene Sandman; Boston, injury, condition, or death described in 2. Willie Johnson; Dublin, Georgia; Massachusetts; Court of Federal the petition is due to factors unrelated Court of Federal Claims No: 16– Claims No: 16–0453V to the administration of the vaccine 0415V 25. Frederick Green; Newport, Rhode described in the petition,’’ and Island; Court of Federal Claims No: 2. Any allegation in a petition that the 3. Maria Villanueva; Utuado, Puerto Rico; Court of Federal Claims No: 16–0454V petitioner either: 26. Linda Commesso; Boston, a. ‘‘[S]ustained, or had significantly 16–0416V Massachusetts; Court of Federal aggravated, any illness, disability, 4. Laura Friedel; Woodstock, Illinois; Claims No: 16–0455V injury, or condition not set forth in the Court of Federal Claims No: 16– 27. Isaac Watson; Indianapolis, Indiana; Vaccine Injury Table but which was 0417V Court of Federal Claims No: 16– caused by’’ one of the vaccines referred 5. Kathleen Mosier; Akron, Ohio; Court 0456V to in the Table, or of Federal Claims No: 16–0418V mstockstill on DSK3G9T082PROD with NOTICES 28. Patricia Swanson; Beverly, b. ‘‘[S]ustained, or had significantly 6. Christina Osenbach and Bryan Massachusetts; Court of Federal aggravated, any illness, disability, Osenbach on behalf of B. O.; Claims No: 16–0457V injury, or condition set forth in the Boston, Massachusetts; Court of 29. Betty D. Backman; Manhattan, Vaccine Injury Table the first symptom Federal Claims No: 16–0419V Kansas; Court of Federal Claims No: or manifestation of the onset or 7. Meredith Pyers; Columbus, Ohio; 16–0458V significant aggravation of which did not Court of Federal Claims No: 16– 30. Sandra E. Williams on behalf of occur within the time period set forth in 0421V Richard Williams, Deceased; VerDate Sep<11>2014 21:20 Jun 02, 2016 Jkt 238001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\03JNN1.SGM 03JNN1

Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices 35785 Surprise, Arizona; Court of Federal 53. John Neukom; Normangee, Texas; 76. Scott Pudalov; Boulder, Colorado; Claims No: 16–0459V Court of Federal Claims No: 16– Court of Federal Claims No: 16– 31. Linda K. Russell; Tampa, Florida; 0495V 0532V Court of Federal Claims No: 16– 54. Heather Wright on behalf of B. W.; 77. Tracy Butler; Denver, Colorado; 0460V Washington, District of Columbia; Court of Federal Claims No: 16– 32. Steven Patton; Vienna, Virginia; Court of Federal Claims No: 16– 0534V Court of Federal Claims No: 16– 0498V [FR Doc. 2016–13073 Filed 6–2–16; 8:45 am] 0461V 55. Julian Henley; Scottsbluff, Nebraska; BILLING CODE 4165–15–P 33. Scott Cipa; Vienna, Virginia; Court Court of Federal Claims No: 16– of Federal Claims No: 16–0462V 0499V 34. Jessica Buckingham; New Castle, 56. Misty Pasco on behalf of M. P.; DEPARTMENT OF HEALTH AND Delaware; Court of Federal Claims Phoenix, Arizona; Court of Federal HUMAN SERVICES No: 16–0463V Claims No: 16–0500V 35. Mette Rose and Soren Rose Kjaer on 57. Janis Pool; Lawrence, Kansas; Court Office of the Secretary behalf of F. R. K.; New York, New of Federal Claims No: 16–0503V York; Court of Federal Claims No: 58. Jeffrey A. Bales; Greensboro, North Findings of Research Misconduct 16–0465V Carolina; Court of Federal Claims 36. Mette Rose and Soren Rose Kjaer on No: 16–0505V AGENCY: Office of the Secretary, HHS. behalf of M. R. K.; New York, New 59. Terry Bartee; Antioch, California; ACTION: Notice. York; Court of Federal Claims No: Court of Federal Claims No: 16– 16–0466V 0506V SUMMARY: Notice is hereby given that 37. Victoria Pusateri; Southgate, 60. Linda Barton; Lancaster, the Office of Research Integrity (ORI) Michigan; Court of Federal Claims Pennsylvania; Court of Federal has taken final action in the following No: 16–0467V Claims No: 16–0508V case: 38. Nathaniel Paul; Fairfax, Virginia; 61. Richard George Laux; Farmington Karen M. D’Souza, Ph.D., University Court of Federal Claims No: 16– Hills, Michigan; Court of Federal of Chicago: Based on the report of an 0468V Claims No: 16–0509V investigation conducted by the 39. Rebecca S. Melgares; Milwaukee, 62. Judith A. Pannick; Flint, Michigan; University of Chicago (UC) and Wisconsin; Court of Federal Claims Court of Federal Claims No: 16– additional analysis conducted by ORI in No: 16–0470V 0510V its oversight review, ORI found that Dr. 40. Arthur L. Trollinger; Graham, North 63. Laura Kerrin; Philadelphia, Karen M. D’Souza, former Research Carolina; Court of Federal Claims Pennsylvania; Court of Federal Professional Associate, Department of No: 16–0473V Claims No: 16–0511V Surgery, UC, engaged in research 41. Tracy E. Carrozza; Princeton, New 64. Rev. Andrew Thomas Moody on misconduct in research supported by Jersey; Court of Federal Claims No: behalf of E. G. M.; Houston, Texas; National Heart, Lung, and Blood 16–0474V Court of Federal Claims No: 16– Institute (NHLBI), National Institutes of 42. Allen O. Cabansag; Spring Valley, 0513V Health (NIH), grants K08 HL081472 and California; Court of Federal Claims 65. James Ritchie; Ponte Vedra Beach, R01 HL107949. No: 16–0475V Florida; Court of Federal Claims No: ORI found that falsified and/or 43. Luciana Desa; Washington, District 16–0514V fabricated data were included in the of Columbia; Court of Federal 66. Thomas Smith; Weston, West following one (1) funded NIH grant, two Claims No: 16–0476V Virginia; Court of Federal Claims (2) publications, two (2) posters, and 44. Deborah Tebault on behalf of J. T.; No: 16–0520V one (1) presentation: Phoenix, Arizona; Court of Federal 67. Shahid Mahroof; Stony Brook, New • R01 HL107949–01 Claims No: 16–0478V York; Court of Federal Claims No: • J Biol Chem. 285(18):13748–60, 2010 45. Stephen Vasas; Ann Arbor, 16–0521V Apr 30 (hereafter referred to as ‘‘JBC Michigan; Court of Federal Claims 68. Stephanie Smith; Allentown, 2010’’) No: 16–0479V Pennsylvania; Court of Federal • J Biol Chem. 286(17):15507–16, 2011 46. Theresa Hibbs; Shepherdsville, Claims No: 16–0522V Apr 29 (hereafter referred to as ‘‘JBC Kentucky; Court of Federal Claims 69. Monika Piatek on behalf of N. P.; 2011’’) No: 16–0481V Chicago, Illinois; Court of Federal • Gordon Conference 2006 poster: 47. Stephanie Gilbert on behalf of P. L.; Claims No: 16–0524V ‘‘Regulation of Myocardial b- Vienna, Virginia; Court of Federal 70. Patricia Rubio; Bedford, New Adrenergic Receptor Signaling By Claims No: 16–0484V Hampshire; Court of Federal Claims Protein Kinase C’’ (hereafter referred 48. Sonya Tabor; Beverly Hills, No: 16–0525V to as ‘‘GC2006’’) California; Court of Federal Claims 71. Frederick Morrison; Gulf Breeze, • Huggins 2010 poster: Gaq-mediated No: 16–0485V Florida; Court of Federal Claims No: activation of GRK2 by mechanical 49. The Estate of Frank Lee Kapp, Jr., 16–0526V stretch in cardiac myocytes; the role Deceased; Salisbury, North 72. Gary Schilling; Boston, of protein kinase C’’ (hereafter Carolina; Court of Federal Claims Massachusetts; Court of Federal referred to as ‘‘HP2010’’) No: 16–0487V Claims No: 16–0527V • Cardiac Research Day 2009 50. Leslie Lewis; Lexington, South 73. Tiffany Harris on behalf of A. H.; presentation: ‘‘Regulation of G mstockstill on DSK3G9T082PROD with NOTICES Carolina; Court of Federal Claims Boston, Massachusetts; Court of protein-coupled receptor signaling by No: 16–0488V Federal Claims No: 16–0528V 51. Christine Benshoff; Orwigsburg, 74. Lianna Roberts; Boston, mechanical stretch in cardiac Pennsylvania; Court of Federal Massachusetts; Court of Federal myocytes’’ (hereafter referred to as Claims No: 16–0489V Claims No: 16–0529V ‘‘CR2009’’) 52. Robert Hearn; Jackson, Mississippi; 75. Jennifer Young; Canton, Michigan; ORI found that Respondent reused Court of Federal Claims No: 16– Court of Federal Claims No: 16– and falsely relabeled and/or falsely 0493V 0530V spliced Western blot images, falsified VerDate Sep<11>2014 21:20 Jun 02, 2016 Jkt 238001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\03JNN1.SGM 03JNN1


Document Created: 2018-02-08 07:29:37
Document Modified: 2018-02-08 07:29:37
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
ContactFor information about requirements for filing petitions, and the Program in general, contact the Clerk, United States Court of Federal Claims, 717 Madison Place NW., Washington, DC 20005, (202) 357-6400. For information on HRSA's role in the Program, contact the Director, National Vaccine Injury Compensation Program, 5600 Fishers Lane, Room 08N146B, Rockville, MD 20857; (301) 443-6593, or visit our Web site at: http://www.hrsa.gov/vaccinecompensation/ index.html.
FR Citation81 FR 35783 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR